← 產業報告目錄

Europe Dermal Fillers Market Research Research Report - Forecast to 2032

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2024-04-02頁數 130報告編號 MRF-ccb9c6d431

授權報價

Single User Price$2,950 USD
Multi User Licence (up to 10 users)$3,950 USD
Enterprisewide Price (Global Site License)$5,250 USD
洽詢購買 申請 Sample

報告摘要

Europe Dermal Fillers Market Research Report Forecast to 2032 Market Overview Dermal filler is a gel-like substance that is injected underneath the skin to restore lost volume, often creases and smooth lines or enhance facial contours. Dermal fillers usage has rapidly grown in recent years because of various offerings in the enhancing aesthetic and rejuvenate improvements that were previously only achievable with surgeries. These are becoming very popular for facial rejuvenation methods. Being minimally invasive dermal filler shows instantaneous results in cosmetic volume replacement therapies. Dermal fillers can be defined as soft tissue fillers injected into the skin for the restoration of smooth appearance and the reduction of wrinkles and other signs of the aging process. The rapidly expanding range of dermal filler products and their increased benefits are fueling the preference rates of dermal fillers among medical professionals as well as patients. The growing demand for facial aesthetics, increasing inclination towards the use of dermal fillers, a rise in the number of plastic surgeons performing cosmetic surgeries, and the decreased procedural cost of dermal fillers in comparison to the cosmetic surgeries are driving the dermal fillers market. However, the side-effects associated with such facial injectables, coupled with the increasing black market for dermal fillers, and emergence of COVID-19 coronavirus is likely to curb the growth of the dermal fillers market. Nevertheless, the rise in the number of clinical trial studies for increasing efficiency rates of dermal fillers will create lucrative opportunities for the growth of the market during the assessment period. Market Segmentation Based on type, the Europe dermal fillers market has been segmented into botulinum toxin, calcium hydroxylapatite, hyaluronic acid, polyalkylimide, poly-L-lactic acid, polymethyl-methacrylate microspheres (PMMA), and others. Based on product, the Europe dermal fillers market has been segmented into biodegradable, non-biodegradable, synthetic neurotoxins. On the basis of application, the Europe dermal fillers market has been segmented into facial line correction, face lift, lip enhancement, facial scars, nasolabial folds, and others. Based on country, the Europe dermal filler market has been segmented into Germany, France, UK, Italy, Spain, Denmark, Finland, Iceland, Norway, Sweden, and Rest of Europe. Germany accounted for the largest market share in 2022. However, France is projected to grow at fastest growing during the forecast period. Major Players The key market players are Merz Pharma GmbH & Co. KGaA, Sinclair Pharma, Ipsen SA (Ipsen), ADODERM GmbH, BioScience GmbH, Allergan Inc. (Allergan), Galderma develops aesthetics, Teoxane, Dr. Korman, and Medytox.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 16 2 MARKET INTRODUCTION 18 2.1 DEFINITION 18 2.2 SCOPE OF THE STUDY 18 2.3 RESEARCH OBJECTIVE 18 2.4 MARKET STRUCTURE 19 3 RESEARCH METHODOLOGY 20 3.1 OVERVIEW 20 3.2 DATA FLOW 22 3.2.1 Data Mining Process 22 3.3 PURCHASED DATABASE: 23 3.4 SECONDARY SOURCES: 24 3.4.1 Secondary Research data flow: 25 3.5 PRIMARY RESEARCH: 26 3.5.1 Primary Research DATA FLOW: 27 3.5.2 Primary Research: Number of Interviews conducted 28 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 28 3.6.1 Revenue Analysis Approach 28 3.7 DATA FORECASTING 29 3.7.1 Data forecasting Technique 30 3.8 DATA MODELLING 31 3.8.1 microeconomic factor analysis: 31 3.8.2 Data Modelling: 32 3.9 TEAMS AND ANALYST CONTRIBUTION 34 4 MARKET DYNAMICS 36 4.1 INTRODUCTION 36 4.2 DRIVERS 36 4.2.1 GROWING DEMAND FOR FACIAL AESTHETICS 36 4.2.2 INCREASING NUMBER OF AESTHETIC PROCEDURES PERFORMED BY PLASTIC SURGEONS 37 4.2.3 Rapid advancements in technology 38 4.3 RESTRAINTS 38 4.3.1 SIDE-EFFECTS ASSOCIATED WITH DERMAL FILLERS 38 4.4 OPPORTUNITY 41 4.4.1 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 41 5 MARKET FACTOR ANALYSIS 42 5.1 PORTER’S FIVE FORCES MODEL 42 5.1.1 Threat of New Entrants 43 5.1.2 Bargaining Power of Suppliers 43 5.1.3 Threat of Substitutes 43 5.1.4 Bargaining Power of Buyers 43 5.1.5 Intensity of Rivalry 43 5.2 IMPACT OF COVID-19 ON THE EUROPE DERMAL FILLERS MARKET 44 5.2.1 impact on supply chain 44 5.2.2 IMPACT ON KEY PLAYERS 44 5.3 NUMBER OF DERMAL FILLER PROCEDURES, BY COUNTRY- 2019-2032 45 5.4 TOTAL NUMBER OF PRIVATE DERMATOLOGY CLINICS, BY COUNTRY (2022) 45 6 EUROPE DERMAL FILLERS MARKET, BY TYPE 47 6.1 OVERVIEW 47 6.2 BOTULINUM TOXIN 50 6.3 CALCIUM HYDROXYLAPATITE 52 6.4 HYALURONIC ACID 54 6.5 POLY-L-LACTIC ACID 56 6.6 POLYALKYLIMIDE 58 6.7 POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) 60 6.8 OTHERS 62 7 EUROPE DERMAL FILLERS MARKET, BY PRODUCT 64 7.1 OVERVIEW 64 7.2 BIODEGRADABLE 66 7.3 NON-BIODEGRADABLE 67 7.4 SYNTHETIC NEUROTOXIN 68 8 EUROPE DERMAL FILLERS MARKET, BY APPLICATION 69 8.1 OVERVIEW 69 8.2 FACIAL LINE CORRECTION 72 8.3 FACE LIFT 73 8.4 LIP ENHANCEMENT 74 8.5 FACIAL SCARS 75 8.6 NASOLABIAL FOLDS 76 8.7 OTHERS 77 9 EUROPE DERMAL FILLERS MARKET, BY COUNTRY 78 9.1 OVERVIEW 78 9.2 EUROPE 78 9.2.1 Germany 81 9.2.2 France 82 9.2.3 United Kingdom 84 9.2.4 Spain 85 9.2.5 Italy 87 9.2.6 Denmark 88 9.2.7 Finland 90 9.2.8 Iceland 91 9.2.9 Norway 93 9.2.10 Sweden 95 9.2.11 Rest of Europe 97 10 COMPETITIVE LANDSCAPE 100 10.1 INTRODUCTION 100 10.2 COMPETITOR DASHBOARD 101 10.3 KEY DEVELOPMENTS & GROWTH STRATEGIES 102 10.3.1 product launch 102 10.3.2 Agreement launch 102 11 COMPANY PROFILES 103 11.1 IPSEN SA 103 11.1.1 COMPANY OVERVIEW 103 11.1.2 FINANCIAL OVERVIEW 104 11.1.3 PRODUCTS OFFERED 104 11.1.4 KEY DEVELOPMENTS 105 11.1.5 SWOT ANALYSIS 105 11.1.6 KEY STRATEGIES 105 11.2 ADODERM GMBH 106 11.2.1 COMPANY OVERVIEW 106 11.2.2 FINANCIAL OVERVIEW 106 11.2.3 PRODUCTS OFFERED 107 11.2.4 KEY DEVELOPMENTS 107 11.2.5 KEY STRATEGIES 107 11.3 BIOSCIENCE GMBH 108 11.3.1 COMPANY OVERVIEW 108 11.3.2 FINANCIAL OVERVIEW 109 11.3.3 PRODUCTS OFFERED 109 11.3.4 KEY DEVELOPMENTS 109 11.3.5 KEY STRATEGIES 109 11.4 ALLERGAN, INC. 110 11.4.1 COMPANY OVERVIEW 110 11.4.2 FINANCIAL OVERVIEW 110 11.4.3 Products OFFERed 111 11.4.4 KEY DEVELOPMENTS 111 11.4.5 SWOT ANALYSIS 112 11.4.6 Key Strategy 112 11.5 MERZ PHARMA GMBH & CO. KGAA 113 11.5.1 COMPANY OVERVIEW 113 11.5.2 FINANCIAL OVERVIEW 113 11.5.3 PRODUCTS OFFERED 114 11.5.4 KEY DEVELOPMENTS 114 11.5.5 SWOT ANALYSIS 115 11.5.6 KEY STRATEGIES 115 11.6 GALDERMA 116 11.6.1 COMPANY OVERVIEW 116 11.6.2 FINANCIAL OVERVIEW 116 11.6.3 PRODUCTS OFFERED 117 11.6.4 KEY DEVELOPMENTS 117 11.6.5 SWOT ANALYSIS 118 11.6.6 KEY STRATEGIES 118 11.7 SINCLAIR PHARMA 119 11.7.1 COMPANY OVERVIEW 119 11.7.2 FINANCIAL OVERVIEW 119 11.7.3 PRODUCTS OFFERED 120 11.7.4 KEY DEVELOPMENTS 120 11.7.5 KEY STRATEGIES 120 11.8 TEOXANE 121 11.8.1 COMPANY OVERVIEW 121 11.8.2 FINANCIAL OVERVIEW 122 11.8.3 productS OFFERED 122 11.8.4 KEY DEVELOPMENTS 122 11.8.5 KEY STRATEGIES 122 11.9 DR. KORMAN 123 11.9.1 COMPANY OVERVIEW 123 11.9.2 FINANCIAL OVERVIEW 124 11.9.3 products OFFERED 124 11.9.4 KEY DEVELOPMENTS 124 11.9.5 KEY STRATEGIES 124 11.10 MEDYTOX 125 11.10.1 COMPANY OVERVIEW 125 11.10.2 FINANCIAL OVERVIEW 126 11.10.3 productS OFFERED 126 11.10.4 KEY DEVELOPMENTSs 126 11.10.5 SWOT ANALYSIS 127 11.10.6 KEY STRATEGIES 127 12 DATA CITATIONS 128
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELLING FOR MARKET SHARE ASSESSMENT 32 TABLE 2 NUMBER OF DERMAL FILLER PROCEDURES, BY COUNTRY- 2019-2032 45 TABLE 3 TOTAL NUMBER OF PRIVATE DERMATOLOGY CLINICS, BY COUNTRY (2022) 45 TABLE 4 EUROPE DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD MILLION) 49 TABLE 5 EUROPE DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (NUMBER IN VOLUME) 49 TABLE 6 EUROPE DERMAL FILLERS MARKET, FOR BOTULINUM TOXIN, BY COUNTRY, 2019–2032 (USD MILLION) 50 TABLE 7 EUROPE DERMAL FILLERS MARKET, FOR BOTULINUM TOXIN, BY COUNTRY, 2019–2032 (NUMBER OF PROCEDURE) 51 TABLE 8 EUROPE DERMAL FILLERS MARKET, FOR CALCIUM HYDROXYLAPATITE, BY COUNTRY, 2019–2032 (USD MILLION) 52 TABLE 9 EUROPE DERMAL FILLERS MARKET, FOR CALCIUM HYDROXYLAPATITE, BY COUNTRY, 2019–2032 (NUMBER OF PROCEDURE) 53 TABLE 10 EUROPE DERMAL FILLERS MARKET, FOR HYALURONIC ACID, BY COUNTRY, 2019–2032 (USD MILLION) 54 TABLE 11 EUROPE DERMAL FILLERS MARKET, FOR HYALURONIC ACID, BY COUNTRY, 2019–2032 (N NUMBER OF PROCEDURE) 55 TABLE 12 EUROPE DERMAL FILLERS MARKET, FOR POLY-L-LACTIC ACID, BY COUNTRY, 2019–2032 (USD MILLION) 56 TABLE 13 EUROPE DERMAL FILLERS MARKET, FOR POLY-L-LACTIC ACID, BY COUNTRY, 2019–2032 (N NUMBER OF PROCEDURE) 57 TABLE 14 EUROPE DERMAL FILLERS MARKET, FOR POLYALKYLIMIDE, BY COUNTRY, 2019–2032 (USD MILLION) 58 TABLE 15 EUROPE DERMAL FILLERS MARKET, FOR POLYALKYLIMIDE, BY COUNTRY, 2019–2032 (N NUMBER OF PROCEDURE) 59 TABLE 16 EUROPE DERMAL FILLERS MARKET, FOR POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA), BY COUNTRY, 2019–2032 (USD MILLION) 60 TABLE 17 EUROPE DERMAL FILLERS MARKET, FOR POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA), BY COUNTRY, 2019–2032 (NUMBER OF PROCEDURE) 61 TABLE 18 EUROPE DERMAL FILLERS MARKET, FOR OTHERS, BY COUNTRY, 2019–2032 (USD MILLION) 62 TABLE 19 EUROPE DERMAL FILLERS MARKET, FOR OTHERS, BY COUNTRY, 2019–2032 (NUMBER OF PROCEDURE) 63 TABLE 20 EUROPE DERMAL FILLERS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 65 TABLE 21 EUROPE DERMAL FILLERS MARKET, FOR BIODEGRADABLE, BY COUNTRY, 2019–2032 (USD MILLION) 66 TABLE 22 EUROPE DERMAL FILLERS MARKET, FOR NON-BIODEGRADABLE, BY COUNTRY, 2019–2032 (USD MILLION) 67 TABLE 23 EUROPE DERMAL FILLERS MARKET, FOR SYNTHETIC NEUROTOXIN, BY COUNTRY, 2019–2032 (USD MILLION) 68 TABLE 24 EUROPE DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 71 TABLE 25 EUROPE DERMAL FILLERS MARKET, FOR FACIAL LINE CORRECTION, BY COUNTRY, 2019–2032 (USD MILLION) 72 TABLE 26 EUROPE DERMAL FILLERS MARKET, FOR FACE LIFT, BY COUNTRY, 2019–2032 (USD MILLION) 73 TABLE 27 EUROPE DERMAL FILLERS MARKET, FOR LIP ENHANCEMENT, BY COUNTRY, 2019–2032 (USD MILLION) 74 TABLE 28 EUROPE DERMAL FILLERS MARKET, FOR FACIAL SCARS, BY COUNTRY, 2019–2032 (USD MILLION) 75 TABLE 29 EUROPE DERMAL FILLERS MARKET, FOR NASOLABIAL FOLDS, BY COUNTRY, 2019–2032 (USD MILLION) 76 TABLE 30 EUROPE DERMAL FILLERS MARKET, FOR OTHERS, BY COUNTRY, 2019–2032 (USD MILLION) 77 TABLE 31 EUROPE: EUROPE DERMAL FILLERS MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 80 TABLE 32 GERMANY: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 81 TABLE 33 GERMANY: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 81 TABLE 34 GERMANY: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 81 TABLE 35 GERMANY: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 82 TABLE 36 FRANCE: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 82 TABLE 37 FRANCE: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 83 TABLE 38 FRANCE: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 83 TABLE 39 FRANCE: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 83 TABLE 40 UNITED KINGDOM: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 84 TABLE 41 UNITED KINGDOM: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 84 TABLE 42 UNITED KINGDOM: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 84 TABLE 43 UNITED KINGDOM: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 85 TABLE 44 SPAIN: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 85 TABLE 45 SPAIN: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 86 TABLE 46 SPAIN: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 86 TABLE 47 SPAIN: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 86 TABLE 48 ITALY: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 87 TABLE 49 ITALY: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 87 TABLE 50 ITALY: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 87 TABLE 51 ITALY: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 88 TABLE 52 DENMARK: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 88 TABLE 53 DENMARK: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 89 TABLE 54 DENMARK: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 89 TABLE 55 DENMARK: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 89 TABLE 56 FINLAND: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 90 TABLE 57 FINLAND: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 90 TABLE 58 FINLAND: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 90 TABLE 59 FINLAND: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 91 TABLE 60 ICELAND: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 91 TABLE 61 ICELAND: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 91 TABLE 62 ICELAND: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 92 TABLE 63 ICELAND: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 92 TABLE 64 NORWAY: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 93 TABLE 65 NORWAY: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 93 TABLE 66 NORWAY: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 94 TABLE 67 NORWAY: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 94 TABLE 68 SWEDEN: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 95 TABLE 69 SWEDEN: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 96 TABLE 70 SWEDEN: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 96 TABLE 71 SWEDEN: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 96 TABLE 72 REST OF EUROPE: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 97 TABLE 73 REST OF EUROPE: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 97 TABLE 74 REST OF EUROPE: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 97 TABLE 75 REST OF EUROPE: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 98 TABLE 76 PRODUCT LAUNCH 102 TABLE 77 AGREEMENT LAUNCH 102 TABLE 78 IPSEN SA : PRODUCTS OFFERED 104 TABLE 79 IPSEN SA : SWOT ANALYSIS 105 TABLE 80 ADODERM GMBH: PRODUCTS OFFERED 107 TABLE 81 BIOSCIENCE GMBH: PRODCUTS OFFERED 109 TABLE 82 ALLERGAN, INC.: PRODUCTS OFFERED 111 TABLE 83 MERZ PHARMA GMBH & CO. KGAA: PRODUCTS OFFERED 114 TABLE 84 MERZ PHARMA GMBH & CO. KGAA: KEY DEVELOPMENTS 114 TABLE 85 GALDERMA: PRODCUTS OFFERED 117 TABLE 86 SINCLAIR PHARMA: PRODUCTS OFFERED 120 TABLE 87 SINCLAIR PHARMA: KEY DEVELOPMENTS 120 TABLE 88 TEOXANE: PRODUCT OFFERED 122 TABLE 89 DR. KORMAN: PRODUCT OFFERED 124 TABLE 90 MEDYTOX: PRODUCT OFFERED 126 LIST OF FIGURES FIGURE 1 EUROPE DERMAL FILLER MARKET: STRUCTURE 19 FIGURE 2 EUROPE DERMAL FILLERSMARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 36 FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 38 FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 39 FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: EUROPE DERMAL FILLERS MARKET 42 FIGURE 6 EUROPE DERMAL FILLERS MARKET, TYPE SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION) 48 FIGURE 7 EUROPE DERMAL FILLERS MARKET, BY TYPE, 2022 & 2032 (USD MILLION) 48 FIGURE 8 EUROPE DERMAL FILLERS MARKET SHARE (%), BY TYPE, 2022 50 FIGURE 9 EUROPE DERMAL FILLERS MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION) 64 FIGURE 10 EUROPE DERMAL FILLERS MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION) 65 FIGURE 11 EUROPE DERMAL FILLERS MARKET SHARE (%), BY PRODUCT, 2022 65 FIGURE 12 EUROPE DERMAL FILLERS MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION) 70 FIGURE 13 EUROPE DERMAL FILLERS MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION) 70 FIGURE 14 EUROPE DERMAL FILLERS MARKET SHARE (%), BY APPLICATION, 2022 71 FIGURE 15 EUROPE MARKET ANALYSIS: DERMAL FILLERS MARKET, 2019-2032 (USD MILLION) 79 FIGURE 16 EUROPE: EUROPE DERMAL FILLERS MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 79 FIGURE 17 EUROPE: EUROPE DERMAL FILLERS MARKET SHARE (%), BY COUNTRY, 2022 80 FIGURE 18 COMPETITOR DASHBOARD: EUROPE DERMAL FILLERS MARKET 101 FIGURE 19 IPSEN SA : FINANCIAL OVERVIEW SNAPSHOT 104 FIGURE 20 ALLERGAN, INC.: SWOT ANALYSIS 112 FIGURE 21 MERZ PHARMA GMBH & CO. KGAA: SWOT ANALYSIS 115 FIGURE 22 GALDERMA: SWOT ANALYSIS 118 FIGURE 23 MEDYTOX: SWOT ANALYSIS 127  

提及公司

Merz Pharma GmbH & Co. KGaASinclair PharmaIpsen SA (Ipsen)ADODERM GmbHBioScience GmbHAllergan Inc. (Allergan)Galderma develops aestheticsTeoxaneDr. Kormanand Medytox.

同分類最新報告(醫療與生命科學)

量子訊息有限公司為 Market Research Future 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們